Actively Recruiting
The CROCO Study: CROhn's Disease COhort Study
Led by GLSMED Learning Health S.A. · Updated on 2024-12-11
600
Participants Needed
20
Research Sites
465 weeks
Total Duration
On this page
Sponsors
G
GLSMED Learning Health S.A.
Lead Sponsor
A
AbbVie
Collaborating Sponsor
AI-Summary
What this Trial Is About
The investigators propose to create a prospective Crohn Disease cohort, where patients receiving the most up-to-date therapies with a treat-to-target strategy, will be closely followed to characterize the progression of Crohn Disease by measuring the Lémann Index over time. The goal of the CROCO Study - "Crohn's Disease Cohort Study" is to promote a greater understanding of the long-term evolution of Crohn Disease , to describe prospectively the impact of different therapeutic strategies and develop accurate predictors of bowel disease damage and disability.
CONDITIONS
Official Title
The CROCO Study: CROhn's Disease COhort Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Crohn Disease according to ECCO guidelines within the past 12 months
- Able to understand study information and provide written informed consent
- Male or female aged over 18 years
You will not qualify if you...
- Unwilling or unable to provide written informed consent
- Severe medical disorder with life expectancy less than 2 years
- Medical conditions or refusal preventing cross-sectional imaging during follow-up (e.g., Glomerular filtration rate < 30 mL/min)
- Uncertain diagnosis of Crohn Disease
- Pregnancy or other reasons making MRI scans impossible throughout the study (e.g., claustrophobia)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 20 locations
1
University Hospital CHU of Liège
Liège, Liège, Belgium
Actively Recruiting
2
American Gastroenterology Center
Stróvolos, Cyprus
Actively Recruiting
3
IBD Clinical and Research Clinic, ISCARE
Prague, Czechia
Actively Recruiting
4
Hvidovre Hospital
Hvidovre, Denmark
Actively Recruiting
5
Slagelse Hospital
Slagelse, Denmark
Actively Recruiting
6
CHU Amiens-Picardie Hôpital Sud
Amiens, France
Actively Recruiting
7
CHU Estaing Clermont - Ferrand
Clermont-Ferrand, France
Actively Recruiting
8
Claude Huriez Hospital, Lille University
Lille, France
Actively Recruiting
9
Azienda Ospedaliera di Padova
Padova, Italy
Not Yet Recruiting
10
Ospedale San Raffaele
San Raffaele, Italy
Withdrawn
11
Mater dei hospital
Msida, Malta
Actively Recruiting
12
Hospital Garcia da Orta
Almada, Almada, Portugal
Actively Recruiting
13
Instituto Portugues de Oncologia de Lisboa
Lisbon, Lisbon District, Portugal
Actively Recruiting
14
Hospital Beatriz Angelo
Loures, Loures, Portugal
Actively Recruiting
15
Algomed Policlinic
Timișoara, Romania
Actively Recruiting
16
Hospital Clinic Barcelona
Barcelona, Spain
Actively Recruiting
17
Hospital Galdakao-Usansolo
Galdakao, Spain
Actively Recruiting
18
Hospital Alvaro Cunqueiro - Área Sanitária de Vigo
Vigo, Spain
Actively Recruiting
19
Hull University Teaching Hospitals NHS Trust
Hull, United Kingdom
Actively Recruiting
20
St Mark's Hospital
London, United Kingdom
Actively Recruiting
Research Team
R
Raquel C Ribeiro, Dr
CONTACT
R
Rita C Eça, Dr
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here